Challenges in Diagnosing Fabry Disease and Their Impact on the Market
Fabry disease often goes underdiagnosed due to its rarity and symptom overlap with other conditions. Early symptoms like pain, fatigue, and gastrointestinal issues are nonspecific, delaying diagnosis.
Diagnostic challenges impact market growth by limiting patient identification and timely treatment initiation. However, increasing use of genetic testing, biomarker identification, and newborn screening programs are improving detection rates.
Better diagnosis translates to increased demand for therapies, positively influencing the Fabry Disease Market. Stakeholders are focusing on awareness campaigns and diagnostic advancements to tackle these challenges.
Learn more about diagnosis trends and market impact at the Fabry Disease Market.